F20
510(k) K103433
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK103433 | Date3 Jan 2011 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NDN
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3027
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
F20 is a bone cement intended for use in percutaneous cementoplasty procedures, such as vertebroplasty or kyphoplasty. It functions as a substance to replace cortical or cancellous bone in a vertebral body.
This sterile, self-curing, medium viscosity bone cement is supplied as a ready-to-use product. It features a high content of radiopaque agent and is designed for low exothermic properties during the curing process. The device is subject to FDA 510(k) authorization.
Other devices from Teknimed, S.A.
Questions
AI-generated answers, 6 Oct 2026
What is the F20 bone cement used for?
F20 is a sterile, self-curing bone cement designed for percutaneous cementoplasty procedures, including vertebroplasty and kyphoplasty. It serves as a replacement for cortical or cancellous bone within a vertebral body.
What are the key physical characteristics of F20?
The device is supplied as a ready-to-use product. It is formulated with a high content of radiopaque agent and is engineered to exhibit low exothermic properties during the curing process.
What is the regulatory status and viscosity of F20?
F20 is a medium viscosity bone cement. It has received FDA 510(k) authorization for its intended use in orthopedic procedures.